Truxima
Truxima
Truxima (rituximab-abbs) is an FDA-approved biosimilar to Rituxan (Rituximab) used to treat adults with Rheumatoid Arthritis (RA) with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough.
It is also used to treat adults with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA): with glucocorticoids.
Administration Information
Truxima is administered intravenously. One course of treatment includes 2 infusions given 2 weeks apart. Infusions generally take 4 to 6 hours. Truxima is typically administered every 6 months, or based on your doctor’s evaluation of your symptoms. If your symptoms return before it’s time for your next course, you and your physician may decide to treat earlier (but no sooner than 4 months).
Your doctor should check you for Hepatitis B before starting Truxima.
Your doctor may give you certain medicines before infusions to help reduce side effects such as acetaminophen and/or diphenhydramine HCI.
Potential Side Effects
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read
